Original Research
Published on 01 Jul 2024
Discussion of the classification of pediatric drug clinical trials in children's hospitals in China
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1409270
- 578 views
- Frontiers in Medicine
- Regulatory Science
- Articles
Type at least 3 characters
384 articles
Articles
Original Research
Published on 27 Jun 2024
Showcasing the Saudi e-referral system experience: the epidemiology and pattern of referrals utilising nationwide secondary data
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1348442
- 1,738 views
Policy Brief
Published on 24 Jun 2024
Balancing ethical norms and duties for the introduction of new medicines through conditional marketing authorization: a research agenda
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1408553
- 973 views
Systematic Review
Published on 21 Jun 2024
Systematic review on the implementation of metrological assurance systems for medical devices in Latin America
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1281199
- 1,536 views
Original Research
Published on 17 Jun 2024
Lessons learned: avoiding bias via multi-state analysis of patients’ trajectories in real-time
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1390549
- 672 views
Original Research
Published on 17 Jun 2024
Development of the CDISC Pediatrics User Guide: a CDISC and conect4children collaboration
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1370916
- 1,270 views
Original Research
Published on 12 Jun 2024
Protection from prior natural infection vs. vaccination against SARS-CoV-2—a statistical note to avoid biased interpretation
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1376275
- 707 views
Mini Review
Published on 10 Jun 2024
New clinical insight in amyotrophic lateral sclerosis and innovative clinical development from the non-profit repurposing trial of the old drug guanabenz
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1407912
- 992 views
Brief Research Report
Published on 05 Jun 2024
Clinical development and marketing application review times for novel orphan-designated drugs
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1404922
- 928 views
Original Research
Published on 05 Jun 2024
Streamlining intersectoral provision of real-world health data: a service platform for improved clinical research and patient care
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1377209
- 1,474 views
Review
Published on 05 Jun 2024
A decade of collaboration in medicines regulation: healthcare professionals engaging with the European Medicines Agency
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1399947
- 977 views
Review
Published on 03 Jun 2024
Navigating the challenges of clinical trial professionals in the healthcare sector
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1400585
- 14,625 views
Review
Published on 03 Jun 2024
Artificial intelligence in healthcare: an Italian perspective on ethical and medico-legal implications
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1343456
- 1,462 views
- 1 citation
Original Research
Published on 31 May 2024
International regulatory and publicly-funded initiatives to advance drug repurposing
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1387517
- 970 views
Original Research
Published on 30 May 2024
Current situation and issues regarding termination of risk management plans in Japan
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1387652
- 945 views
- 1 citation
Technology and Code
Published on 27 May 2024
Transforming evidence-based clinical guidelines into implementable clinical decision support services: the CAREPATH study for multimorbidity management
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1386689
- 1,690 views
- 1 citation